Professor, Pediatrics, USC School of Medicine

Pediatric Rheumatology

Dr. Andreas O. Reiff practices Pediatric Rheumatology. He received 2 awards: "Top Doctors:LA Area" and "Super Doctor". Andreas O. Reiff, MD is also published. He has 43 publications published. The lastest publication: "Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography.'

Publications

---

• Transition of Care and Health-Related Outcomes in Pediatric-Onset Systemic Lupus Erythematosus.
• Treatment of pediatric takayasu Arteritis with infliximab and cyclophosphamide: experience from an american-brazilian cohort study.
• Rheumatic inflammatory eye Diseases of childhood.
• Exome Sequencing Reveals RAG1 Mutations in a Child with Autoimmunity and Sterile Chronic Multifocal Osteomyelitis Evolving into Disseminated Granulomatous Disease.
• T lymphocyte abnormalities in Juvenile systemic sclerosis patients.
• Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic Arthritis.
• High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic Lupus erythematosus in different racial groups.
• Treatment of Systemic Juvenile Idiopathic Arthritis with Tocilizumab - the Role of Anti-Interleukin-6 Therapy After a Decade of Treatment.
• Prolonged efficacy of etanercept in refractory enthesitis-related Arthritis.
• Etanercept in children with polyarticular juvenile rheumatoid Arthritis. Pediatric Rheumatology Collaborative Study Group.
• Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid Arthritis.
• Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid Arthritis.
• Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid Arthritis: interim results from an ongoing multicenter, open-labe...
• Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid Arthritis.
• Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic Arthritis.
• Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic Arthritis.
• Primary angiitis of the central nervous system in children: 5 cases.
• Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase.
• Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasone.
• Childhood central nervous system Lupus; longitudinal assessment using single photon emission computed tomography.
• Adalimumab with or without methotrexate in juvenile rheumatoid Arthritis.
• Identification of novel susceptibility genes in childhood-onset systemic Lupus erythematosus using a uniquely designed candidate gene pathway platform.
• Treatment of collagen induced Arthritis in DBA/1 mice with L-asparaginase.
• Scleroderma-like skin changes not involving the hand in a prepubertal male with type I diabetes mellitus: A case report.
• Ocular complications of childhood rheumatic Diseases: uveitis.
• Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory Juvenile polymyositis.
• Identification of new SLE-associated genes with a two-step Bayesian study design.
• Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic Lupus erythematosus.
• Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic Lupus erythematosus.
• Etanercept therapy in children with treatment-resistant uveitis.
• Case series: neuropsychiatric symptoms with pediatric systemic Lupus erythematosus.
• Study of thymic size and function in children and adolescents with treatment refractory systemic sclerosis eligible for immunoablative therapy.
• A review of Campath in autoimmune Disease: biologic therapy in the gray zone between immunosuppression and immunoablation.
• Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid Arthritis: a 12-week randomized ...
• Anakinra in the treatment of polyarticular-course juvenile rheumatoid Arthritis: safety and preliminary efficacy results of a randomized multicenter study.
• The use of anakinra in juvenile Arthritis.
• High dose methotrexate in the treatment of refractory juvenile rheumatoid Arthritis.
• Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid Arthritis.
• Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid Arthritis and juvenile dermatomyositis.
• B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic Arthritis patients.
• Adalimumab in juvenile rheumatoid Arthritis/juvenile idiopathic Arthritis.
• Developments in the treatment of juvenile Arthritis.

Conditions Treated

---

• Amyloidosis
• Ankylosing Spondylitis
• Arthritis
• Classic PolyArteritis Nodosa
• View All

Doctors Specialties

---

• Pediatric Rheumatology

Accepted Insurances

---

Awards

---

• Top Doctors:LA Area
• Super Doctor

Education

---

• University of Freiburg Faculty of Medicine

Hospital

---

• Long Beach Memorial Medical Center
• Torrance Memorial Medical Center
• Children's Hospital Los Angeles

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Robert M. Sheets, MD This Doctor is OpenDoctor Recommended.
	Dr. Wendy L. De La Pena, MD
	Dr. Katherine A. Marzan, MD This Doctor is OpenDoctor Recommended.
	Dr. Sheryl J. Boon, MD This Doctor is OpenDoctor Recommended.
	Dr. Bracha S. Shaham, MD This Doctor is OpenDoctor Recommended.
	Dr. Diane E. Brown, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog